Zimmer, L. (6 November 2015). Open‑label, multicenter, single‑arm phase II DeCOG‑study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma. Journal of translational medicine, 13, . doi:10.1186/s12967-015-0716-5

"Open‑label, multicenter, single‑arm phase II DeCOG‑study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma / Lisa Zimmer, Thomas K. Eigentler, Felix Kiecker, Jan Simon, Jochen Utikal, Peter Mohr, Carola Berking, Eckhart Kämpgen, Edgar Dippel, Rudolf Stadler, Axel Hauschild, Michael Fluck, Patrick Terheyden, Rainer Rompel, Carmen Loquai, Zeinab Assi, Claus Garbe and Dirk Schadendorf" Journal of Translational Medicine .

Zimmer, Lisa. "Open‑label, Multicenter, Single‑arm Phase II DeCOG‑study of Ipilimumab in Pretreated Patients With Different Subtypes of Metastatic Melanoma." Journal of Translational Medicine 13 (6 November 2015).